|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-1-16
|
|
pubmed:abstractText |
To study the effects of intravitreal bevacizumab (Avastin) on retinal neovascularization (RN) in patients with proliferative diabetic retinopathy (PDR).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1476-5454
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
117-23
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17891058-Adult,
pubmed-meshheading:17891058-Aged,
pubmed-meshheading:17891058-Aged, 80 and over,
pubmed-meshheading:17891058-Angiogenesis Inhibitors,
pubmed-meshheading:17891058-Antibodies, Monoclonal,
pubmed-meshheading:17891058-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:17891058-Diabetic Retinopathy,
pubmed-meshheading:17891058-Female,
pubmed-meshheading:17891058-Fluorescein Angiography,
pubmed-meshheading:17891058-Humans,
pubmed-meshheading:17891058-Injections, Intralesional,
pubmed-meshheading:17891058-Male,
pubmed-meshheading:17891058-Middle Aged,
pubmed-meshheading:17891058-Retinal Neovascularization,
pubmed-meshheading:17891058-Retrospective Studies,
pubmed-meshheading:17891058-Treatment Outcome,
pubmed-meshheading:17891058-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up.
|
|
pubmed:affiliation |
Retina and Vitreous Service, Clinica Oftalmológica Centro Caracas, Caracas, Venezuela. arevalojf2020@gmail.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
